文献速递肾移植

肾移植抗体介导排斥反应检测方法间关系界定

Defining Relationships Among Tests for Kidney Transplant Antibody-Mediated Rejection.
PubMed 文献 · Kidney Int Rep · 2025-06-17

Trifecta-Kidney研究分析717例指征活检,评估组织学、分子显微镜诊断系统(MMDx)、供体来源游离DNA(dd-cfDNA)和供体特异性抗体(DSA)四种抗体介导排斥反应(ABMR)检测方法的相关性。结果显示四者呈部分相关网络,MMDx与DSA相关性不低于组织学与DSA,且分子排斥对移植物结局预测优于组织学。

要点

  • 四种ABMR检测方法相互关联,相关强度MMDx > dd-cfDNA > 组织学 > DSA。
  • DSA与MMDx ABMR的相关性不低于与组织学ABMR的相关性。
  • 分子排斥预测移植物结局优于组织学排斥,需明确亚阈值ABMR活动的临床意义。

核心结论

  • 四种ABMR相关检测方法构成相关网络,可提高ABMR评估精确性。
  • 分子排斥预测移植物结局优于组织学排斥,亚阈值ABMR活动需进一步研究。

研究设计与样本

  • Trifecta-Kidney研究(NCT04239703)分析717例指征活检,定义四种ABMR检测方法间关系。

主要发现

  • 四种检测方法在部分相关网络中相关,相关强度顺序为MMDx ABMR > dd-cfDNA > 组织学ABMR > DSA。
  • DSA与MMDx ABMR相关性至少与组织学ABMR相当,尽管MMDx未使用DSA。
  • 组织学与MMDx ABMR不一致时,dd-cfDNA和DSA与MMDx评估相关性更强。
  • 组织学在部分MMDx判定无排斥病例中检测到ABMR病变,与亚阈值分子ABMR活动、dd-cfDNA和DSA相关。
  • 分子排斥预测移植物结局优于组织学排斥,该发现在INTERCOMEX队列中得到确认。

临床怎么用

  • 联合使用组织学、MMDx、dd-cfDNA和DSA可提高ABMR评估精确性。
  • 关注亚阈值ABMR活动的临床意义,可能影响临床管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Effective therapies for kidney transplant antibody-mediated rejection (ABMR) will require accurate diagnoses plus assessment of ABMR activity, and the new tests that were used to show treatment effects in the clinical trial such as donor-derived cell-free DNA (dd-cfDNA) and molecular biopsy analysis (the Molecular Microscope Diagnostic System) could be useful. METHODS: Trifecta-Kidney (ClinicalTrials.gov #NCT04239703) studied 717 indication biopsies to define the relationships among the following 4 tests used for ABMR: (i) standard-of-care (SOC) local histologic biopsy ABMR diagnosis, (ii) MMDx ABMR diagnosis, (iii) dd-cfDNA, and (iv) donor-specific antibody (DSA). RESULTS: All 4 tests were correlated in a partial correlation network, with a hierarchy of intertest correlations: MMDx ABMR > dd-cfDNA > histology ABMR > DSA. Surprisingly, DSA correlated at least as strongly with MMDx ABMR as with histologic ABMR, even though DSA is not used in MMDx. When expressed in the same 6 rejection classes, MMDx diagnosed ABMR more frequently than histology. When histology disagreed with MMDx ABMR, dd-cfDNA and DSA correlated more strongly with MMDx assessment. However, histology also detected ABMR lesions in some cases that MMDx called No Rejection, correlating with subthreshold molecular ABMR activity, dd-cfDNA and DSA (AJT 25:72-87, 2024). Molecular rejection predicted graft outcomes better than histologic rejection in Trifecta-Kidney, and this finding was confirmed in the earlier INTERCOMEX study cohort. DISCUSSION: The 4-way intertest correlations extend below current thresholds for diagnosing ABMR. These results map a network of 4 ABMR-related tests that can add precision to ABMR assessment in trials and clinical management, and highlight the need to establish the clinical significance of subthreshold ABMR activity.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Madill-Thomsen KS, Hidalgo LG, Demko ZP, et al. Defining Relationships Among Tests for Kidney Transplant Antibody-Mediated Rejection. Kidney Int Rep. 2025. PMID: 40980666. doi:10.1016/j.ekir.2025.06.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。